In describing the investigational product's physical, chemical, and pharmaceutical properties, which item must be included?

• A. Marketing plan
• B. Excipients used in the formulation
• C. Manufacturing facility location
• D. Color of the packaging

Answer: (B)

Describing the investigational product’s physical, chemical, and pharmaceutical properties requires listing all components that make up the formulation, including the excipients. Excipients are part of the product’s composition and can affect stability, solubility, dissolution, bioavailability, and safety; regulators need to know every substance present to assess quality and replicate the product consistently across batches. Therefore, including the excipients used in the formulation is essential.

Marketing plans, manufacturing facility location, and packaging color don’t describe the product’s intrinsic properties. They relate to commercialization, production logistics, or packaging design, which are addressed in other sections of regulatory documentation.